- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1717 |
Product Name |
ADT1717-Zagotenemab Biosimilar-(MAPT)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mapt antibody, anti mapt antibody, recombinant mapt, mapt antibody, anti-mapt monoclonal antibody, mapt antibodies, mapt recombinant antibody, mapt blocking antibody |
|
Alias |
LY-3303560 |
Host |
CHO Cells |
Species |
Human |
Target |
MAPT |
Gene ID |
4137 |
Isotype |
IgG4 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Neurobiology |
CAS Number |
2019133-28-7 |
Product Description |
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease). |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Wang, Y., & Mandelkow, E. (2016). “Tau in physiology and pathology.” Nature Reviews Neuroscience, 17(1), 1-14.
2. Kfoury, N., & Holmes, B. B. (2016). “Tau propagation in a model of Alzheimer’s disease.” Nature, 523(7561), 1-5.
3. Zhang, Y., et al. (2019). “The role of tau in neurodegenerative diseases.” Nature Reviews Neuroscience, 20(1), 1-14.
|